Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 5;128(23):3138-42.
doi: 10.4103/0366-6999.170364.

Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery

Yan Qiu, Jing Lin, Yang Yang, Jing Zhou, Li-Na Gong, Zhen Qin, Lei Du  1
Affiliations

Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery

Yan Qiu et al. Chin Med J (Engl). .

Abstract

Background: It was believed that inflammatory response induced by cardiopulmonary bypass (CPB) was blamed for complications after cardiac surgery. To improve the outcome, many pharmacological interventions have been applied to attenuate inflammatory response during CPB. The objective of this study was to investigate the effect of ulinastatin (urinary trypsin inhibitor [UTI]) on outcome after CPB surgery.

Methods: Totally, 208 patients undergoing elective valves replacement between November 2013 and September 2014 were divided into Group U (n = 70) and Group C (n = 138) based on they received UTI or not. Categorical variables were compared between groups using Fisher's exact test, and continuous variables using unpaired Student's t-test or Mann-Whitney U-test. One-way analysis of variance and Dunnett's or Tukey's tests were used to compare values at different time points within the same group. The risk of outcomes was estimated and adjusted by multivariable logistic regression, propensity scoring, and mixed-effect models for all measured variables.

Results: Both the serious complications in total, including death, acute lung injury, acute respiratory distress syndrome and acute kidney injury, and the other complications, including hemodialysis, infection, re-incubation, and tracheotomy were similar between the two groups (P > 0.05). After adjusted by multivariable logistic regression and the propensity score, UTI still cannot be found any benefit to improve any outcomes after cardiac surgery. Also, no statistical differences with regard to duration of postoperative mechanical ventilation, the length of Intensive Care Unit and hospital stays (P > 0.05).

Conclusion: UTI did not improve postoperative outcomes in our patients after cardiopulmonary bypass surgery.

PubMed Disclaimer

References

    1. Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist. Anesthesiology. 2002;97:215–52. - PubMed
    1. Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg. 1997;85:766–82. - PubMed
    1. Ng CS, Wan S. Limiting inflammatory response to cardiopulmonary bypass: Pharmaceutical strategies. Curr Opin Pharmacol. 2012;12:155–9. - PubMed
    1. Warren OJ, Smith AJ, Alexiou C, Rogers PL, Jawad N, Vincent C, et al. The inflammatory response to cardiopulmonary bypass: Part 1 – Mechanisms of pathogenesis. J Cardiothorac Vasc Anesth. 2009;23:223–31. - PubMed
    1. Vohra HA, Whistance R, Modi A, Ohri SK. The inflammatory response to miniaturised extracorporeal circulation: A review of the literature. Mediators Inflamm 2009. 2009 707042. - PMC - PubMed

Publication types